Sage Journals: Discover world-class research

Abstract

French

Mitochondrial dysfunction is commonly observed in bipolar disorder (BD) and schizophrenia (SCZ) and may be a central feature of psychosis. These illnesses are complex and heterogeneous, which is reflected by the complexity of the processes regulating mitochondrial function. Mitochondria are typically associated with energy production; however, dysfunction of mitochondria affects not only energy production but also vital cellular processes, including the formation of reactive oxygen species, cell cycle and survival, intracellular Ca²⁺ homeostasis, and neurotransmission. In this review, we characterize the upstream components controlling mitochondrial function, including 1) mutations in nuclear and mitochondrial DNA, 2) mitochondrial dynamics, and 3) intracellular Ca²⁺ homeostasis. Characterizing and understanding the upstream factors that regulate mitochondrial function is essential to understand progression of these illnesses and develop biomarkers and therapeutics.

Keywords

psychosis bipolar disorder schizophrenia mitochondria

Highlights

Mitochondrial dysfunction is frequently reported in both bipolar disorder (BD) and schizophrenia (SCZ).

This may lead to increased generation of reactive oxygen species (ROS).

ROS may react with cellular macromolecules to alter signaling pathways, decompensate myelin, and cause damage to DNA and RNA.

Mutations in mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) may produce mitochondrial dysfunction in BD and SCZ.

Disrupted mitochondrial fusion, fission, and trafficking may impair mitochondrial function in SCZ.

Enhanced release of Ca²⁺ from the endoplasmic reticulum in BD and SCZ may lead to mitochondrial Ca²⁺ overload, disrupting function.

Introduction

Bipolar disorder (BD) and schizophrenia (SCZ) are severe psychiatric disorders with a lifetime prevalence exceeding 3% of the population worldwide.¹ These disorders are characterized by clinical features such as mania and depression in BD or hallucinations and delusions in SCZ. Relapse and recurrent psychosis are common to both disorders, causing lifelong disease burden and impairment.^2,3 Understanding the etiology and pathophysiology of these disorders is necessary to develop biomarkers and rational therapeutics to ease their burden. Substantial evidence exists suggesting a role for mitochondrial dysfunction in the pathophysiology of major psychoses.^4
–6 Although mitochondria are traditionally associated with adenosine triphosphate (ATP) production, they are also crucial in regulating cell cycle,⁷ death and survival,⁸ intracellular Ca²⁺ homeostasis,⁹ and neurotransmission.¹⁰ The brain in particular is affected by dysfunction in mitochondria due to its high energy demands and sensitivity to oxidative damage.¹¹ Because neurotransmitter release and cell survival are dependent on ATP production and Ca²⁺ homeostasis, mitochondrial dysfunction can alter synaptic connectivity, which may in turn produce symptoms of psychosis.^12,13 Understanding mitochondrial function will be crucial to comprehend disease progression and to develop rational therapeutics to improve the quality of life of patients with psychiatric illness.

Three of the major upstream pathways that may impair mitochondrial function in BD and SCZ include 1) mutations in nuclear and mitochondria DNA, 2) altered mitochondrial dynamics, and 3) perturbed Ca²⁺ flux. BD and SCZ are complex diseases that cannot be characterized by a singular narrow pathway. Rather, numerous subtle alterations likely converge upon particular pathways (i.e., mitochondrial function) to produce functional alterations. Thus, examining upstream pathways that control mitochondrial function will lead to a more comprehensive understanding of the etiology and pathophysiology of BD and SCZ. In this review, will address how these interrelated upstream processes may contribute to mitochondrial dysfunction in major psychosis.

Mitochondrial Dysfunction in Major Psychosis

Mitochondria are a major endogenous source of reactive oxygen species (ROS).¹⁴ During normal mitochondrial metabolism, only a small proportion of electrons escape the electron transport chain (ETC), mainly through complex I.¹⁵ These electrons reduce O₂ to produce superoxide anion, which is then dismutated by superoxide dismutase (SOD) to yield hydrogen peroxide (H₂O₂) (Figure 1B).¹⁶ In the presence of reduced transition metals, H₂O₂ may further react to form a hydroxyl radical.¹⁶ Hydroxyl radicals are highly reactive and can oxidize nucleic acids, lipids, and proteins (Figure 1C).^17,18 ROS are strong oxidants and important signaling molecules, whose effects are balanced by antioxidants,^19,20 such as glutathione, SOD, and glutathione peroxidase (GPx).²¹ Dysregulation of the ETC may lead to greater proportion of electrons escaping and forming ROS.²² When ROS production exceeds the capacity of antioxidant networks, the cell is subjected to oxidative stress.^15,18 The brain in particular is susceptible to oxidative stress due to its high-energy demand, easily oxidized polyunsaturated fatty acids, and relatively low antioxidant capacity.^23,24 Compromised mitochondrial function can disrupt neuronal oxidative metabolism. This may alter neurotransmission and neuronal growth, 2 highly energy-dependent processes, producing symptoms of psychosis and altered mood.^15,25

Figure 1.
(A) Mitochondrial dynamic: fusion process is important for mitochondrial function by diffusion of metabolites and enzymes between mitochondria, as well as dilution of damaged proteins and DNA. The fusion mediators are Mfn1 and Mfn2, which is present on the outer mitochondrial membrane, and Opa1, which is located in the inner mitochondria membrane. Fission process can isolate injured mitochondria, contributing to mitochondrial quality control. The fission mediators are Fis1 and Drp1. Fis1 recruits Drp1 to mitochondria, and it permits the development of fission process. (B) Normal mitochondrial function: mitochondrial and electron transport chain (ETC) assembly and function are dependent on nuclear DNA (nDNA) and mitochondrial DNA DNA (mtDNA)–encoded proteins. nDNA-encoded proteins regulate mitochondrial replication, transcription, and repair, allowing for crosstalk between nDNA and mtDNA. Mitochondria take up Ca²⁺ primarily through mitochondrial Ca²⁺ uniporter (MCU). Ca²⁺ is then extruded from mitochondria through ion exchangers that are coupled to adenosine triphosphate (ATP) production. Mitochondria are localized close to sites of Ca²⁺ entry, such as the endoplasmic reticulum (ER) and membrane channels, allowing them to buffer cytosolic Ca²⁺ concentrations. (C) Mitochondrial dysfunction: ETC impairment increases the amount of electrons leakage, resulting in increased reactive oxygen species (ROS) production. High levels of ROS coupled with low antioxidant defenses disrupt redox homeostasis, leading to cellular oxidative stress. Antioxidant defenses include superoxide dismutase (SOD) and glutathione peroxidase (GPx). If these high levels of ROS are not sufficiently detoxified by these antioxidant enzymes, it can cause oxidative damage to proteins, lipids, and nucleic acids.

Complex I is the first structure of the ETC that catalyzes the transfer of electrons from NADH to ubiquinone²⁶ and is also the major site of ROS generation in the ETC.^27,28 Dysfunction of mitochondrial complex I is a commonly observed phenomenon in BD and SCZ. A recent review of microarray studies found a consistent downregulation of genes encoding subunits of complex I, including NDUFV1, NDUFS1, NDUFS8, and NDUFS7, in postmortem frontal cortex (PFC) and hippocampus samples of subjects with BD.⁴ The subunits that were found to be downregulated in BD formed the catalytic core of complex I involved specifically in electron transfer from NADH to ubiquinone,²⁹ suggesting that patients with BD may be susceptible to electron leakage through complex I. In contrast, patients with SCZ presented with inconsistent alterations, which included increased and decreased gene expression levels of both structural and catalytic subunits.⁴ In agreement with these findings, a previous study demonstrated decreased NDUFS7 protein levels in the PFC of subjects with BD but not SCZ, which were associated with decreased complex I activity.³⁰ Interestingly, the mood stabilizer Li⁺ was found to increase expression of complex I subunits in postmortem brains and activity level in vivo of subjects with BD.^31,32 These findings suggests that while complex I dysfunction is present in both disorders, impairments in electron transfer may be more specific to BD (Table 1).

Table 1.
Summary of Pertinent Findings Discussed of Mitochondrial-Related Alterations in Patients with BD and SCZ.

Markers BD SCZ Sample Type References

Mitochondrial complex I NDUFV1 ↓ — Postmortem prefrontal cortex and hippocampus Scola et al.,⁴ Andreazza et al.³⁰

NDUFS1 ↓ —

NDUFS8 ↓ —

NDUFS7 ↓ —

mtDNA polymorphisms A10398G (ND3) R NA Peripheral blood Kato et al.⁵⁴

T12027C (ND4) NA R Postmortem brain Marchbanks et al.⁵⁷

T3644TC (ND1) R NA Transmitochondrial cybrids Munakata et al.⁵⁸

nDNA polymorphisms −796C>G (NDUFV2 at 18p11) R NA Lymphoblastoid cells Washizuka et al.,⁶⁰ Washizuka et al.⁶¹

−795T>G (NDUFV2 at 18p11) R NA

−602G>A (NDUFV2 at 18p11) R NA

−233T>C (NDUFV2 at 18p11) R NA

nDNA-mtDNA crosstalk DNA polymerase subunit γ ↓ — Lymphoblastoid cells, peripheral blood mononuclear cells Kato et al.,⁶⁶ Munkholm et al.⁶⁷

Lipid peroxidation Malondialdeyhyde ↑ ↑ Peripheral blood Gonzalez-Liencres et al.,³⁸ Kunz et al.,⁴¹ Gubert et al.⁴²

4-Hydroxy-2-nonenal ↑ ↑ Postmortem anterior cingulate and prefrontal cortex Wang et al.,³⁴ Andreazza et al.³⁶

8-Isoprostanes ↑ — Postmortem prefrontal cortex Andreazza et al.³⁶

Antioxidant enzyme Glutathione peroxidase — ↑ Serum Kuloglu et al.⁴³

Protein alterations Carbonyl content ↑ — Postmortem prefrontal cortex Andreazza et al.,³⁰ Andreazza et al.³⁶

3-Nitrotyrosine content ↑ ↑ Postmortem prefrontal cortex, peripheral blood Andreazza et al.,³⁰ Andreazza et al.³⁵

RNA damage 8-Hydroxyguanosine ↑ ↑ Postmortem hippocampus Che et al.⁴⁴

↑, increased; ↓, decreased; —, no specific or significant alteration; R, risk factor; NA, not applicable; BD, bipolar disorder; mtDNA, mitochondrial DNA; nDNA, nuclear DNA; SCZ, schizophrenia.

A major consequence of complex I dysfunction is the generation of ROS, leading to oxidative damage to macromolecules. A number of studies have identified increased oxidative damage markers to protein, lipid, and DNA in BD and SCZ.^{30,33

–38} ROS-induced oxidative damage to lipids, for instance, results in lipid hydroperoxides (LPH), which are unstable and react with other lipids to form products such as 8-isoprostanes (8-ISO), malondialdehyde (MDA), 4-hydroxy-2-nonenal (4-HNE), and acrolein.^39,40 MDA has been frequently found to be elevated in both BD and SCZ^41
–43 and was negatively correlated with complex I activity.⁴² Oxidative damage to fatty acids, which make up myelin, may cause degeneration of white matter tracts and produce abnormalities in neural circuits.⁴⁰ Indeed, elevated levels of 4-HNE have been found in myelin fractions from patients with BD and SCZ, with elevated levels of 8-ISO in BD.³⁶ It is also important to note that many other markers are specific to particular disease states. For example, increased GPx levels were found in SCZ but not BD,⁴³ while protein carbonylation was elevated in BD but not in SCZ.³⁰ Overall, these findings support the hypothesis that mitochondrial dysfunction and oxidative imbalance contribute to the pathophysiology of BD and SCZ. Next, we explore upstream processes involved in controlling mitochondrial and ETC function in the context of BD and SCZ, including mitochondrial and nuclear genomics, mitochondrial dynamics and quality control, and Ca²⁺ homeostasis.

Mitochondrial and Nuclear Genomics

As BD and SCZ show a high degree of heritability,^45,46 studying where genetic mutations occur may provide insight into possible pathways that are dysregulated in these diseases. While genetic alterations related to countless cellular processes have been reported in BD and SCZ,^47,48 we focus on those directly related to ETC function. While mitochondria contain their own DNA, this is not sufficient for function of the ETC.⁴⁹ Both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA)–encoded proteins are essential for ETC assembly (Figure 1B). For example, complex I is composed of 37 nDNA-encoded and 7 mtDNA-encoded subunits. Importantly, a number of nDNA-encoded assembly factors or chaperones are required for the stability and proper assembly of ETC complexes.⁵⁰ nDNA-encoded proteins also regulate the replication, transcription, and repair of mtDNA.^51,52 Therefore, mutations in either nDNA or mtDNA have the potential to directly affect mitochondrial function.

mtDNA mutations likely contribute to BD and SCZ. mtDNA mutations (Table 1) are commonly associated with BD and SCZ. Furthermore, these disorders have higher rates of maternal inheritance than paternal inheritance, which aligns with the fact that mtDNA is inherited exclusively from the mother.^45,53 Dozens of mtDNA single-nucleotide polymorphisms (SNPs) in genes encoding ETC proteins have been associated with BD and SCZ.^54
–56 These SNPs have the potential to affect ETC function. For example, the mtDNA SNP 12027T>C, encoding the ND4 subunit of complex I, is associated with SCZ and with greater production of SOD, suggesting a compensatory response to increased ROS production.⁵⁷ mtDNA SNPs occurring in the ND1 and ND3 subunits of complex I are associated with BD and lead to impaired mitochondrial function in mtDNA cybrids.^54,58 Many other mtDNA SNPs have been associated with BD and SCZ, but the functional consequences of most of these have not been explored. Based on current evidence, it is likely that variants in genes encoding ETC proteins can directly affect mitochondrial function.

Mutations in nDNA are also involved in mitochondrial dysfunction. nDNA-encoded genes are important for the architecture, assembly, and catalytic functions of mitochondrial ETC.⁴⁹ Mutations in nDNA encoding complex I catalytic subunits have been shown to impair mitochondrial function.⁵⁹ Indeed, the complex I subunit NDUFV2 has been identified as a possible risk factor for BD; its gene is found at a well-replicated susceptibility locus for BD (18p11), and SNPs in this gene have been associated with BD.⁶⁰ One particular SNP (–602G>A) is associated with BD and results in decreased promoter activity.⁶¹ Altered NDUFV2 expression levels have been reported in samples of both BD^60,62 and SCZ.⁶³ Downregulation of NDUFS7 has also been reported in BD,^30,31 which was correlated with reduced activity of complex I and increased protein oxidation.³⁰ nDNA-encoded proteins not only make up the majority of the ETC^64,65 but are also required for the stability of the ETC⁵⁰ and the replication, transcription, and repair of mtDNA.^51,52 For example, DNA polymerase subunit gamma (Polγ), which is responsible for the replication of mtDNA, is downregulated in peripheral cells of patients with BD.^66,67 Interestingly, transgenic mice expressing neuron-specific mutant Polγ accumulate mtDNA mutations and demonstrate mood disorder–like behavior that is worsened by tricyclic antidepressants and improved by Li⁺.⁶⁸ The association between genes and symptoms in psychiatric disorders is often complex, but identifying risk genes may help shed light on potential mechanisms and therapeutic targets for these disorders.^55,69,70

Mitochondrial Dynamics and Trafficking

Mitochondria are dynamic organelles that undergo changes in morphology and localization; these changes affect cellular processes such as ATP production, mitosis, and mitophagy.^71
–73 Mitophagy is a quality control process in which damaged mitochondria are degraded in lysosomes. Alterations in mitochondrial dynamics have been implicated in neurodegenerative diseases.⁷⁴ Initial investigations in psychiatric illnesses have suggested a role for altered mitochondrial dynamics in SCZ. However, these processes have not been thoroughly investigated in either SCZ or BD. Future research may help to answer these questions.

Mitochondrial dynamics involve changes in mitochondrial morphology through fusion and fission, as well as movement through the cells via microtubule motor proteins (Figure 1A).^71,75,76 Fusion promotes diffusion of contents between mitochondria, spreading metabolites and enzymes,⁷⁷ diluting damaged proteins and DNA, and increasing communications with the endoplasmic reticulum.^74,78 On the other hand, fission is necessary for cell division and for maintaining mitochondrial quality control; damaged mitochondria are isolated by fission and subject to mitophagy.⁷⁷ Thus, both fission and fusion are necessary for optimal mitochondrial and cell function.

The fusion process is mediated by Mitofusin 1 (Mfn1), Mitofusin 2 (Mfn2),^75,79 and optic atrophy 1 (Opa1) protein.⁷⁴ Mfn2 is also crucial for mitochondrial tethering to ER membranes, forming mitochondria-associated ER membranes (MAMs).⁸⁰ MAMs allow for the transport of Ca²⁺ and lipids from the ER to mitochondria and are important for mitophagy.^80,81 Knockout of Mfn2 in cells leads to fragmentation of mitochondria, disrupted MAMs,⁸⁰ and impaired mitophagy.⁸² The role of fusion in psychiatric illnesses has not been established yet, but one analysis of postmortem prefrontal cortex samples revealed decreased levels of Opa1 in SCZ specimens.⁸³

Mitochondrial fission is essential for cell proliferation and mitophagy.^84,85 The main mediators of fission are mitochondrial fission 1 protein (Fis1) and dynamin-related protein 1 (Drp1).^74,86 However, few studies to date have established the role for Fis1 and Drp1 in BD and SCZ; these represent potential targets for future investigation.⁸³ An interesting mechanism for altered mitochondrial dynamics in SCZ is through G72. G72 has previously been identified as a candidate gene for SCZ,⁸⁷ and levels of G72 protein appear to be substantially higher in the plasma of both medicated and unmedicated patients with SCZ.⁸⁸ While originally thought to modulate NMDA signaling, a recent investigation demonstrated that transfection of G72 into primary neurons induces mitochondrial fragmentation and increases dendritic branching.⁸⁹ Cells expressing a loss-of-function Drp1 mutant, which have impaired fission, exhibit drastically reduced fragmentation in response to G72.⁸⁹ Overexpression of G72 may promote mitochondrial fission and lead to altered neural connectivity. G72 is not only a promising peripheral biomarker but may also contribute to mitochondrial dysfunction in SCZ.

Mitochondrial dynamics involve not only the processes of fission and fusion but also movement of mitochondria through the cell.⁷¹ The trafficking and localization of mitochondria in neurons are influenced by ATP and Ca⁺² concentration.⁹⁰ High levels of ATP increase mitochondrial motility in dendrites to areas of high energy demand⁹¹; in contrast, high levels of ADP and Ca²⁺ inhibit movement.^91
–93 Because localization of mitochondria is important for Ca²⁺ homeostasis¹⁰ and ATP provision,⁹⁴ impairment in mitochondrial trafficking can produce alterations in neurotransmitter release and synaptic function.^90,95 A key protein involved in mitochondrial trafficking is disrupted in schizophrenia (Disc1).^71,96 Disc1 associates with kinesin-1, which is necessary for the anterograde movement of mitochondria.⁹⁴ In yeast, decreased Disc1 function results in decreased complex I activity and ATP production, as well as perturbed Ca²⁺ buffering.⁹⁷ The Disc1 SNP R37 W decreases Disc1 expression⁹⁸ and impairs anterograde movement of mitochondria.⁹⁴ Other Disc1 SNPs are associated with SCZ and BD, although the functional consequences are unknown.^94,99,100 Currently available research suggests that mitochondrial dynamics are impaired in SCZ, but it is unknown if mitochondrial dynamics are involved in other psychiatric illnesses.

The Role of Calcium Homeostasis in Mitochondrial Dysfunction

Among other functions, Ca²⁺ influences cell metabolism, death/survival, and neurotransmission through regulation of the mitochondria. The primary uptake mechanism for Ca²⁺ by mitochondria is through the mitochondrial Ca²⁺ uniporter (MCU).^101,102 While the affinity of the MCU for Ca²⁺ is low, localization of mitochondria to regions of cytosolic Ca²⁺ influx, such as the ER and membrane channels, allows them to buffer the cell from large spikes in Ca²⁺ concentration.^10,102 Mitochondrial Ca²⁺ is extruded into the cytosol through exchangers that are coupled to the ETC (Figure 1 B).^9,102 Uptake of Ca²⁺ into mitochondria enhances respiration by activating several dehydrogenases in the citric acid cycle.¹⁰³ The subsequent accumulation of NADH leads to an increased production of ATP, which is required to pump Ca²⁺ out of mitochondria.^9,104 While Ca²⁺ is a positive effector of mitochondrial function, Ca²⁺ overload causes uncoupling of the ETC and depolarization of the mitochondrial membrane.^105,106 Ca²⁺ overload therefore decreases the mitochondrion’s capacity to generate ATP and remove Ca²⁺,⁹ inducing ROS production¹⁰⁴ and potentially leading to apoptosis. As mitochondrial ATP production and Ca²⁺ buffering are essential for neurotransmission and cell survival, dysfunction may alter neural plasticity.^10,107

Intracellular Ca²⁺ dyshomeostasis has long been implicated in BD and SCZ. For example, elevated Ca²⁺ are frequently observed in stimulated platelets from patients with untreated SCZ and BD.^108

–112 Such findings are indicative of altered intracellular Ca²⁺ signaling but do not offer specific evidence of the processes involved. The ER is a likely source of Ca²⁺ dysfunction in BD and SCZ. Because the ER is a major source of intracellular Ca²⁺ and closely associated with mitochondria through MAMs, dysfunctions in ER-mediated release of Ca²⁺ affect Ca²⁺ homeostasis within mitochondria.^102,104

The ER releases Ca²⁺ largely through inositol triphosphate receptors (IP₃ R). IP₃ R is an ER membrane Ca²⁺ channel that is activated by IP₃. Dysregulation of Ca²⁺ influx through IP₃Rs disrupts mitochondrial function through Ca²⁺ overload.¹⁰⁴ In neurons, such events alter normal neurotransmitter release and synaptic plasticity.¹⁰ Several lines of evidence suggest a role for IP₃Rs in Ca²⁺ dyshomeostasis in BD and SCZ. Neuronal Ca²⁺ sensor-1 (NCS-1) protein levels are elevated in the dorsolateral PFC of patients with SCZ and BD but not depression.^113,114 NCS-1 increases cytosolic Ca²⁺ levels by enhancing IP₃ R activity; this process is blocked by therapeutic levels of Li⁺.^115,116 Furthermore, Li⁺ and valproate inhibit enzymes in the IP cycle involved in the generation of IP₃, decreasing IP₃ R activity.^117,118 As well, both typical and atypical antipsychotics inhibit IP₃-induced Ca²⁺ release. Patients with untreated BD or SCZ may have altered sensitivity to Ca²⁺-releasing stimuli in part due to overexpression of NCS-1.¹¹⁹

The antiapoptotic protein Bcl-2 also inhibits IP₃-mediated IP₃ R Ca²⁺ release,¹²⁰ thereby protecting mitochondria against Ca²⁺ overload.⁹ Decreased levels of Bcl-2 protein have been reported in the frontal cortex of patients with BD¹²¹ and the temporal cortex of patients with SCZ.^122,123 Bcl-2 SNPs in patients with BD are associated with lower levels of Bcl-2 messenger RNA and protein, elevated basal Ca²⁺, and enhanced IP₃R-mediated Ca²⁺ release.^124,125 Li⁺ has been shown to increase Bcl-2 expression in the central nervous system¹²⁶ and restores Ca²⁺ homeostasis in Bcl-2 variants, further supporting a role for Bcl-2 in BD.¹²⁴ Bcl-2 not only reduces IP₃R-mediated Ca²⁺ release¹²⁰ but also modulates membrane L-type Ca²⁺ channels.¹²⁷ Cells with decreased levels of Bcl-2, such as in BD and SCZ, are therefore at greater risk of mitochondrial Ca²⁺ overload. Ca²⁺ dysregulation observed in BD and SCZ may be in part due to altered IP₃ R activity, leading to enhanced influx of Ca²⁺ from the ER to closely associated mitochondria. Ca²⁺ overload can depolarize the mitochondrial membrane and impair its other functions.^105,106

It is important also to consider that mitochondrial function is crucial in the regulation of intracellular Ca²⁺ levels. Impairments in mitochondrial function have the potential to dysregulate Ca²⁺ homeostasis. For example, the mtDNA SNP 10398G>A, found in the region encoding the complex I subunit ND3, is associated with BD⁵⁴ and with higher mitochondrial pH and Ca²⁺ concentrations.¹²⁸ Moreover, SH-SY5Y cells chronically exposed to rotenone (>2 weeks), which induces 15% to 30% decreases in complex I function, demonstrate altered Ca²⁺ influx in response to stimulation, which is dependent in part on MCU.¹²⁹ This suggests that diminished ETC function, which is commonly observed in BD and SCZ, impairs the mitochondrion’s ability to buffer intracellular Ca²⁺. Mitochondrial ROS can also alter Ca²⁺ flux by modulating redox-sensitive Ca²⁺ channels, such as TRPM2.^130,131 Disruptions in either mitochondrial function or intracellular Ca²⁺ homeostasis have the potential to exacerbate each other.

Concluding Remarks

We have described a role for mitochondrial dysfunction in the pathophysiology of major psychoses and discussed upstream pathways that may contribute to controlling mitochondrial function in BD and SCZ. Upstream pathways can be summarized as mutations in mtDNA and nDNA, perturbed mitochondrial dynamics, and dysregulated intracellular Ca²⁺ homeostasis. BD and SCZ are complex and heterogeneous diseases; it is unlikely that all of these pathways are dysregulated in a given individual. Rather, different individuals may present with alterations in different processes that may converge upon mitochondrial dysfunction. The processes involved in energy production, mitochondrial dynamics, and Ca²⁺ homeostasis are interdependent. Subtle alterations in one process may either be compensated or exacerbated by other processes, contributing to the complexity of these disorders. Despite this, the mitochondrial dysfunction present in BD appears to be distinct from that in SCZ. While both BD and SCZ are associated with mitochondrial dysfunction and redox modulations, BD is associated with decreased protein and gene expression of NDUFS7 and NDUFS8, 2 core subunits for electron transfer in complex I. As these subunits are mandatory for electron transfer to ubiquinone, patients with BD may be more susceptible to ROS generation by electron loss through complex I compared to those with SCZ. Altered expression of complex I subunits is reported in SCZ, but the direction of these findings is inconsistent, unlike the decreased levels observed in BD.⁴

BD features manic and depressive episodes. Studies to date have not been designed to address how mitochondrial function may change in each state of the illness within the same individual. Nevertheless, we might speculate that during manic episodes, patients experience a general increase in neurotransmission; this requires high levels of energy, suggesting an increase in mitochondria activity resulting in increased ATP and ROS production. Overproduction of mitochondrial ROS leads to changes in the redox state of certain proteins, altering their function. This may explain, in part, the cyclical nature of BD. Redox modulations to proteins may decrease mitochondrial activity, altering neurotransmission and producing symptoms of depression. Of course, it should be noted that the above mechanism is speculative, and longitudinal studies examining markers of mitochondrial function are crucial to determine how mitochondrial activity varies between mood states.

Understanding the upstream processes that affect mitochondrial function will help in identifying the different triggers of mitochondrial dysfunction in each of the 2 psychiatric illnesses. Ultimately, delineating the causes of mitochondrial dysfunction will guide rational development of novel therapeutics with better efficacy and fewer adverse effects.

Markers	BD	SCZ	Sample Type	References
Mitochondrial complex I	NDUFV1	↓	—	Postmortem prefrontal cortex and hippocampus	Scola et al.,⁴ Andreazza et al.³⁰
NDUFS1	↓	—
NDUFS8	↓	—
NDUFS7	↓	—
mtDNA polymorphisms	A10398G (ND3)	R	NA	Peripheral blood	Kato et al.⁵⁴
T12027C (ND4)	NA	R	Postmortem brain	Marchbanks et al.⁵⁷
T3644TC (ND1)	R	NA	Transmitochondrial cybrids	Munakata et al.⁵⁸
nDNA polymorphisms	−796C>G (NDUFV2 at 18p11)	R	NA	Lymphoblastoid cells	Washizuka et al.,⁶⁰ Washizuka et al.⁶¹
−795T>G (NDUFV2 at 18p11)	R	NA
−602G>A (NDUFV2 at 18p11)	R	NA
−233T>C (NDUFV2 at 18p11)	R	NA
nDNA-mtDNA crosstalk	DNA polymerase subunit γ	↓	—	Lymphoblastoid cells, peripheral blood mononuclear cells	Kato et al.,⁶⁶ Munkholm et al.⁶⁷
Lipid peroxidation	Malondialdeyhyde	↑	↑	Peripheral blood	Gonzalez-Liencres et al.,³⁸ Kunz et al.,⁴¹ Gubert et al.⁴²
4-Hydroxy-2-nonenal	↑	↑	Postmortem anterior cingulate and prefrontal cortex	Wang et al.,³⁴ Andreazza et al.³⁶
8-Isoprostanes	↑	—	Postmortem prefrontal cortex	Andreazza et al.³⁶
Antioxidant enzyme	Glutathione peroxidase	—	↑	Serum	Kuloglu et al.⁴³
Protein alterations	Carbonyl content	↑	—	Postmortem prefrontal cortex	Andreazza et al.,³⁰ Andreazza et al.³⁶
3-Nitrotyrosine content	↑	↑	Postmortem prefrontal cortex, peripheral blood	Andreazza et al.,³⁰ Andreazza et al.³⁵
RNA damage	8-Hydroxyguanosine	↑	↑	Postmortem hippocampus	Che et al.⁴⁴

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We thank the Brazilian government (CAPES) for supporting AM for his exchange doctorate and TMS in an exchange fellowship (CNPq- SWB). ACA is funded by CHIR (MOP-143439), Ontario Mental Health Foundation, and Ontario Ministry of Research and Innovation (ERA-14-10-022).

References

Perälä

Suvisaari

Saarni

. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64(1):19–28.

Judd

Schettler

Akiskal

. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry. 2008;65(4):386–394.

Emsley

Chiliza

Asmal

Harvey

. The nature of relapse in schizophrenia. BMC Psychiatry. 2013;13(1):50.

Scola

Kim

Young

Andreazza

. A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry. 2013;73(2):e4–e5.

Clay

Sillivan

Konradi

. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 2011;29(3):311–324.

Manji

Kato

Di Prospero

. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci. 2012;13:293–307.

McBride

Neuspiel

Wasiak

. Mitochondria: more than just a powerhouse. Curr Biol. 2006;16(14):R551–R560.

Hockenbery

Nuñez

Milliman

Schreiber

Korsmeyer

. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348(6299):334–336.

Gleichmann

Mattson

. Neuronal calcium homeostasis and dysregulation. Antioxid Redox Signal. 2011;14(7):1261–1273.

10.

Jonas

. BCL-xL regulates synaptic plasticity. Mol Interv. 2006;6(4):208–222.

11.

Uttara

Singh

Zamboni

Mahajan

. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65–74.

12.

Akarsu

Torun

Bolu

. Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features. J Mol Psychiatry. 2014;2(1):6.

13.

Beal

. Oxidatively modified proteins in aging and disease. Free Radic Biol Med. 2002;32(9):797–803.

14.

Streck

Czapski

Gonçalves Da Silva

. Neurodegeneration, mitochondrial dysfunction, and oxidative stress. Oxid Med Cell Longev. 2013;2013:826046.

15.

Malkus

Tsika

Ischiropoulos

. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson’s disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener. 2009;4:24.

16.

Kirkinezos

Moraes

. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol. 2001;12(6):449–457.

17.

Goldstein

Meyerstein

Czapski

. The Fenton reagents. Free Radic Biol Med. 1993;15(4):435–445.

18.

Valko

Leibfritz

Moncol

Cronin

MTD

Mazur

Telser

. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84.

19.

Rhee

. Cell signaling: H₂O₂, a necessary evil for cell signaling. Science. 2006;312(5782):1882–1883.

20.

Liemburg-Apers

Willems

PHGM

Koopman

WJH

Grefte

. Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism. Arch Toxicol. 2015;89(8):1209–1226.

21.

Gorrini

Harris

Mak

. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947.

22.

Ragheb

Lawler

. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003;278(10):8516–8525.

23.

Berk

Dean

Bush

. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851–876.

24.

Halliwell

. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97(6):1634–1658.

25.

LeBel

Bondy

. Oxygen radicals: common mediators of neurotoxicity. Neurotoxicol Teratol. 1991;13(3):341–346.

26.

Zickermann

Kerscher

Zwicker

Tocilescu

Radermacher

Brandt

. Architecture of complex I and its implications for electron transfer and proton pumping. Biochim Biophys Acta Bioenerg. 2009;1787(6):574–583.

27.

Kudin

Bimpong-Buta

NYB

Vielhaber

Elger

Kunz

. Characterization of superoxide-producing sites in isolated brain mitochondria. J Biol Chem. 2004;279(6):4127–4135.

28.

Lambert

Brand

. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH: ubiquinone oxidoreductase (complex I). J Biol Chem. 2004;279(38):39414–39420.

29.

Mimaki

Wang

McKenzie

Thorburn

Ryan

. Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta Bioenerg. 2012;1817(6):851–862.

30.

Andreazza

Shao

Wang

J-F

Young

. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67(4):360–368.

31.

Sun

Wang

Tseng

Young

. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci. 2006;31(3):189–196.

32.

De Sousa

Streck

Zanetti

M V

. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl). 2015;232(1):245–250.

33.

Brown

Andreazza

Young

. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014;218:61–68.

34.

Wang

J-F

Shao

Sun

Young

. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009;11(5):523–529.

35.

Andreazza

Kapczinski

Kauer-Sant’Anna

. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci. 2009;34(4):263–271.

36.

Andreazza

Wang

J-F

Salmasi

Shao

Young

. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem. 2013;127(4):552–561.

37.

Ciobica

Padurariu

Dobrin

Stefanescu

Dobrin

. Oxidative stress in schizophrenia—focusing on the main markers. Psychiatr Danub. 2011;23(3):237–245.

38.

Gonzalez-Liencres

Tas

Brown

. Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition. BMC Psychiatry. 2014;14(1):268.

39.

Negre-Salvayre

Coatrieux

Ingueneau

Salvayre

. Advanced lipid peroxidation end products in oxidative damage to proteins: potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol. 2008;153(1):6–20.

40.

Halliwell

Gutteridge

. Free radicals, lipid peroxidation, and cell damage. Lancet. 1984;2(8411):1095.

41.

Kunz

Gama

Andreazza

. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry. 2008;32(7):1677–1681.

42.

Gubert

Stertz

Pfaffenseller

. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res. 2013;47(10):1396–1402.

43.

Kuloglu

Ustundag

Atmaca

. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002;20(2):171–175.

44.

Che

Wang

Shao

Young

. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci. 2010;35(5):296–302.

45.

Lichtenstein

Yip

Björk

. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373(9659):234–239.

46.

Purcell

Wray

Stone

. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748–752.

47.

Ferreira

MAR

O’Donovan

Meng

. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40(9):1056–1058.

48.

Ripke

O’Dushlaine

Chambert

. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45(10):1150–1159.

49.

Scarpulla

. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008;88(2):611–638.

50.

Diaz

Kotarsky

Fellman

Moraes

. Mitochondrial disorders caused by mutations in respiratory chain assembly factors. Semin Fetal Neonatal Med. 2011;16(4):197–204.

51.

Clayton

. Transcription and replication of mitochondrial DNA. Hum Reprod. 2000;15(Suppl 2):11–17.

52.

Kazak

Reyes

Holt

. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol. 2012;13(11):726–726.

53.

McMahon

Stine

Meyers

Simpson

DePaulo

. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet. 1995;56(6):1277–1286.

54.

Kato

Kunugi

Nanko

Kato

. Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord. 2001;62(3):151–164.

55.

Sequeira

Rollins

Magnan

. Mitochondrial mutations in subjects with psychiatric disorders. PLoS One. 2015;10(5):e0127280.

56.

Martorell

Segués

Folch

. New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet. 2006;14(5):520–528.

57.

Marchbanks

Ryan

Day

INM

Owen

McGuffin

Whatley

. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res. 2003;65(1):33–38.

58.

Munakata

Tanaka

Mori

. Mitochondrial DNA 3644T→C mutation associated with bipolar disorder. Genomics. 2004;84(6):1041–1050.

59.

Pagniez-Mammeri

Lombes

Brivet

. Rapid screening for nuclear genes mutations in isolated respiratory chain complex I defects. Mol Genet Metab. 2009;96(4):196–200.

60.

Washizuka

Kakiuchi

Mori

. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet. 2003;120B(1):72–78.

61.

Washizuka

Iwamoto

Kazuno

. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees. Biol Psychiatry. 2004;56(7):483–489.

62.

Nakatani

Hattori

Ohnishi

. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet. 2006;15(12):1949–1962.

63.

Dror

Klein

Karry

. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry. 2002;7(9):995–1001.

64.

Andreu

DiMauro

. Current classification of mitochondrial disorders. J Neurol. 2003;250(12):1403–1406.

65.

Pecina

Houstková

Hansíková

Zeman

Houstek

. Genetic defects of cytochrome c oxidase assembly. Physiol Res. 2004;53(Suppl 1):S213–S223.

66.

Kato

Hayashi-Takagi

Toyota

Yoshikawa

Iwamoto

. Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet. 2011;56(11):779–783.

67.

Munkholm

Peijs

Vinberg

Kessing

. A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder. Transl Psychiatry. 2015;5(8):e614.

68.

Kasahara

Kubota

Miyauchi

. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry. 2006;11(6):577–593.

69.

Giusti

Mantua

Da Valle

. Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach. Mol Biosyst. 2014;10(6):1246–1254.

70.

Yamamoto

Raudensky

. The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol. 2008;3(4):203–217.

71.

Atkin

MacAskill

Brandon

Kittler

. Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry. 2011;16(2):122–124.

72.

Twig

Elorza

Molina

. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008;27(2):433–446.

73.

Liesa

Shirihai

. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;17(4):491–506.

74.

Archer

. Mitochondrial dynamics—mitochondrial fission and fusion in human diseases. N Engl J Med. 2013;369:2236–2251.

75.

Wang

. Dynamic tubulation of mitochondria drives mitochondrial network formation. Cell Res. 2015;25(10):1108–1120.

76.

Stephen

Gupta Agarwal

Kittler

. Mitochondrial dynamics in astrocytes. Biochem Soc Trans. 2014;42(5):1302–1310.

77.

Westermann

. Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta Bioenerg. 2012;1817(10):1833–1838.

78.

Chen

Vermulst

Wang

. Mitochondrial fusion is required for mtdna stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 2010;141(2):280–289.

79.

Santel

Fuller

. Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001;114(Pt 5):867–874.

80.

De Brito

Scorrano

. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature. 2008;456(7222):605–610.

81.

Vance

. MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond. Biochim Biophys Acta Mol Cell Biol Lipids. 2014;1841(4):595–609.

82.

Hailey

Rambold

Satpute-Krishnan

. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell. 2010;141(4):656–667.

83.

Rosenfeld

Brenner-Lavie

Ari

SGB

Kavushansky

Ben-Shachar

. Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol Psychiatry. 2011;69(10):980–988.

84.

Ehses

Raschke

Mancuso

. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol. 2009;187(7):1023–1036.

85.

Friedman

Nunnari

. Mitochondrial form and function. Nature. 2014;505(7483):335–343.

86.

Chan

. Mitochondrial dynamics in disease. N Engl J Med. 2007;356(17):1707–1709.

87.

Chumakov

Blumenfeld

Guerassimenko

. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci. 2002;99(21):13675–13680.

88.

Lin

C-H

Chang

H-T

Chen

Y-J

. Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals. Mol Psychiatry. 2014;19(6):636–637.

89.

Kvajo

Dhilla

Swor

Karayiorgou

Gogos

. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry. 2008;13(7):685–696.

90.

MacAskill

Atkin

Kittler

. Mitochondrial tracking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci. 2010;32(2):231–240.

91.

MacAskill

Kittler

. Control of mitochondrial transport and localization in neurons. Trends Cell Biol. 2010;20(2):102–112.

92.

Mironov

. ADP regulates movements of mitochondria in neurons. Biophys J. 2007;92(8):2944–2952.

93.

Wang

Schwarz

. The Mechanism of Ca2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell. 2009;136(1):163–174.

94.

Ogawa

Malavasi

EL V

Crummie

. DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking. Hum Mol Genet. 2014;23(4):906–919.

95.

Kang

Tian

Pan

. Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell. 2008;132(1):137–148.

96.

Taya

Shinoda

Tsuboi

. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci. 2007;27(1):15–26.

97.

Park

Y-U

Jeong

Lee

. Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin. Proc Natl Acad Sci U S A. 2010;107(41):17785–17790.

98.

Thomson

Parla

McRae

. 708 Common and 2010 rare DISC1 locus variants identified in 1542 subjects: analysis for association with psychiatric disorder and cognitive traits. Mol Psychiatry. 2014;19(6):668–675.

99.

Mackie

Millar

Porteous

. Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol. 2007;17(1):95–102.

100.

Saetre

Agartz

De Franciscis

. Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophr Res. 2008;106(2-3):237–241.

101.

Santo-Domingo

Demaurex

. Calcium uptake mechanisms of mitochondria. Biochim Biophys Acta Bioenerg. 2010;1797(6-7):907–912.

102.

Rizzuto

De Stefani

Raffaello

Mammucari

. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol. 2012;13(9):566–578.

103.

Nichols

Denton

. Towards the molecular basis for the regulation of mitochondrial dehydrogenases by calcium ions. Mol Cell Biochem 1995;149-150:203–212.

104.

Brookes

. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. AJP Cell Physiol. 2004;287(4):C817–C833.

105.

Schinder

Olson

Spitzer

Montal

. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci. 1996;16(19):6125–6133.

106.

Duchen

. Mitochondria and calcium: from cell signalling to cell death. J Physiol. 2000;529(1):57–68.

107.

Nguyen

Marin

Atwood

. Synaptic physiology and mitochondrial function in crayfish tonic and phasic motor neurons. J Neurophysiol. 1997;78(1):281–294.

108.

Dubovsky

Christiano

Daniell

. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry. 1989;46(7):632–638.

109.

Das

Khan

Puri

Sooranna

de Belleroche

Hirsch

. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun. 1995;212(2):375–380.

110.

Kusumi

Koyama

Yamashita

. Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biol Psychiatry. 1992;32(8):731–734.

111.

Yamawaki

. Enhanced calcium response to serotonin in platelets from patients with affective disorders. J Psychiatry Neurosci. 1996;21(5):321–324.

112.

Suzuki

Kusumi

Sasaki

Koyama

. Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder? J Affect Disord. 2001;64(2-3):291–296.

113.

Koh

Undie

Kabbani

Levenson

Goldman-Rakic

Lidow

. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A. 2003;100(1):313–317.

114.

Bai

Novikova

. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biol Psychiatry. 2004;56(6):427–440.

115.

Koizumi

Rosa

Willars

. Mechanisms underlying the neuronal calcium sensor-1-evoked enhancement of exocytosis in PC12 cells. J Biol Chem. 2002;277(33):30315–30324.

116.

Schlecker

Boehmerle

Jeromin

. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest. 2006;116(6):1668–1674.

117.

Berridge

Downes

Hanley

. Neural and developmental actions of lithium: a unifying hypothesis. Cell. 1989;59(3):411–419.

118.

Eickholt

Towers

Ryves

. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol Pharmacol. 2005;67(5):1426–1433.

119.

Sczekan

Strumwasser

. Antipsychotic drugs block IP3-dependent Ca2+-release from rat brain microsomes. Biol Psychiatry. 1996;40(6):497–502.

120.

Rong

Distelhorst

. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol. 2008;70:73–91.

121.

Kim

H-W

Rapoport

Rao

. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis. 2010;37(3):596–603.

122.

Jarskog

Gilmore

Selinger

Lieberman

. Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry. 2000;48(7):641–650.

123.

Jarskog

Selinger

Lieberman

Gilmore

. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry. 2004;161(1):109–115.

124.

MacHado-Vieira

Pivovarova

Stanika

. The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry. 2011;69(4):344–352.

125.

Uemura

Green

Corson

Perova

Warsh

. Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder. Bipolar Disord. 2011;13(1):41–51.

126.

Chen

Zeng

Yuan

. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 1999;72(2):879–882.

127.

Díaz-Prieto

Herrera-Peco

de Diego

AMG

. Bcl2 mitigates Ca2+ entry and mitochondrial Ca2+ overload through downregulation of L-type Ca2+ channels in PC12 cells. Cell Calcium. 2008;44(4):339–352.

128.

Kazuno

Munakata

Nagai

. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet. 2006;2(8):e128.

129.

Sherer

Trimmer

Borland

Parks

Bennett

Tuttle

. Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Res. 2001;891(1-2):94–105.

130.

Yan

Wei

Zhang

Cheng

Liu

. Cross-talk between calcium and reactive oxygen species signaling. Acta Pharmacol Sin. 2006;27(7):821–826.

131.

Zhong

Zhai

Liang

. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun. 2013;4:1611.

Upstream Pathways Controlling Mitochondrial Function in Major Psychosis

Abstract

Keywords

Highlights

Introduction

Mitochondrial Dysfunction in Major Psychosis

Mitochondrial and Nuclear Genomics

Mitochondrial Dynamics and Trafficking

The Role of Calcium Homeostasis in Mitochondrial Dysfunction

Concluding Remarks

Footnotes

Declaration of Conflicting Interests

Funding

References